SCHEMBL24319650

SCHEMBL24319650

CC1(N2CCN(CC3CCNCC3)CC2)CCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 1/20 0.37
CACNA1B Q00975 1/20 0.37
CACNB1 Q02641 1/20 0.37
CHRM5 P08912 1/20 0.37
ADRA2C P18825 1/20 0.37
ACHE P22303 2/20 0.37
GBA1 P04062 2/20 0.36
SIGMAR1 Q99720 3/20 0.33
GNAO1 P09471 1/20 0.33
SCN1A P35498 1/20 0.33
SCN4A P35499 1/20 0.33
SCN7A Q01118 1/20 0.33
KCNH2 Q12809 1/20 0.33
SCN5A Q14524 1/20 0.33
SCN9A Q15858 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN3A Q9NY46 1/20 0.33
SCN11A Q9UI33 1/20 0.33
SCN8A Q9UQD0 1/20 0.33
SCN10A Q9Y5Y9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24319365 0.82 CACNA2D1 (0.36) CACNA2D1CACNA1BCACNB1CHRM5ADRA2C
SCHEMBL24319651 0.81 NCF1 (0.38) CACNA2D1CACNA1BCACNB1CHRM5ADRA2C
SCHEMBL14422030 0.80 GBA1 (0.48) CACNA2D1CACNA1BCACNB1CHRM5ADRA2C
SCHEMBL24320055 0.79 GNAO1 (0.37) CACNA2D1CACNA1BCACNB1ACHEGBA1
Hydrochloric Acid SCHEMBL5573130 0.78 GBA1 (0.47) CACNA2D1CACNA1BCACNB1CHRM5ADRA2C
SCHEMBL3062251 0.76 CHRM5 (0.56) CACNA2D1CACNA1BCACNB1CHRM5ADRA2C
SCHEMBL528918 0.76 CHRM5 (0.62) CACNA2D1CACNA1BCACNB1CHRM5ADRA2C
SCHEMBL24319495 0.75
SCHEMBL25134177 0.75 GBA1 (0.37) CACNA2D1CACNA1BCACNB1CHRM5ADRA2C
SCHEMBL24319174 0.75 ACHE (0.38) CACNA2D1CACNA1BCACNB1CHRM5ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022047145-A1 RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2022-03-03 WO disclosed